Home
 /
Papers
 /
Cancer Biology
 /
Spatiotemporal lineage tracing reveals the dynamic spatial architecture of tumour growth and metastasis
Preprint
Open access
V1
Top 1% · Validated by QED

Spatiotemporal lineage tracing reveals the dynamic spatial architecture of tumour growth and metastasis

Matthew G. Jones, Dawei Sun, Kyung Hoi (Joseph) Min +28 more
October 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2024.10.21.619529
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Cancer Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By linking subclonal expansion directly to the hypoxic, immunosuppressive niche it creates, this work establishes — with spatial precision — how tumors engineer their own metastatic potential, a causal connection previously inaccessible without integrated spatial lineage tracing.

QED claims analysis

Summary

Integration of spatial transcriptomics with Cas9-based lineage tracing in a mouse model of lung adenocarcinoma reveals that rapid subclonal expansion creates hypoxic tumor interiors that drive sequential microenvironmental remodeling—characterized by immunosuppressive macrophage infiltration, fibroblast activation, and decreased cancer cell plasticity—culminating in the emergence of spatially-confined, pro-metastatic EMT subclones that maintain enhanced fibrotic programs upon dissemination to distant sites.

See full analysis
Main Claim 1 –

Spatial transcriptomics plus Cas9 tracing reconstructs in situ phylogenies

Supporting evidence

  • Spatial imputation recovers missing lineage states with 90% accuracy
  • CNVs independently validate spatial lineage-tracing phylogenetic relationships
Main Claim 2 –

Eleven spatial gene communities track lung tumor progression stages

Main Claim 3 –

Subclonal expansion drives hypoxic interiors and reduced cancer plasticity

Supporting evidence

  • High-fitness niches enrich Arg1+ TAMs and myCAF fibroblasts
  • Expansion niches show rewired signaling for macrophage recruitment and fibrosis
  • Hypoxia plus co-culture synergistically amplifies EMT induction in cancer cells
Main Claim 4 –

Metastases originate from spatially confined primary-tumor subclones

Supporting evidence

  • Metastasis-initiating niches show EMT, hypoxia, TGFβ, and fibrosis programs
  • Metastases sustain EMT and increase collagen deposition versus primaries
  • Human lung metastases preserve mouse-identified metastatic gene programs

Abstract

Tumour progression is driven by dynamic interactions between cancer cells and their surrounding microenvironment. Investigating the spatiotemporal evolution of tumours can provide crucial insights into how intrinsic changes within cancer cells and extrinsic alterations in the microenvironment cooperate to drive different stages of tumour progression. Here, we integrate high-resolution spatial transcriptomics and evolving lineage tracing technologies to elucidate how tumour expansion, plasticity, and metastasis co-evolve with microenvironmental remodelling in a Kras;p53-driven mouse model of lung adenocarcinoma. We find that rapid subclonal expansion contributes to a hypoxic, immunosuppressive, and fibrotic microenvironment that is associated with the emergence of pro-metastatic cancer cell states. Furthermore, metastases arise from spatially-confined subclones of primary tumours and remodel the distant metastatic niche into a fibrotic, collagen-rich microenvironment. Together, we present a comprehensive dataset integrating spatial assays and lineage tracing to elucidate how sequential changes in cancer cell state and microenvironmental structures cooperate to promote tumour progression.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?